These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 26718193

  • 1. Tumour-induced osteomalacia: An emergent paraneoplastic syndrome.
    Alonso G, Varsavsky M.
    Endocrinol Nutr; 2016 Apr; 63(4):181-6. PubMed ID: 26718193
    [Abstract] [Full Text] [Related]

  • 2. The phosphaturic mesenchymal tumor as a cause of oncogenic osteomalacia. Three cases and review of the literature.
    Moreno Romero M, Pérez Muñoz I, González Lizán F, Gallego Rivera JI, Valdivielso Cañas L.
    Rev Esp Cir Ortop Traumatol (Engl Ed); 2021 Apr 23. PubMed ID: 33903024
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1.
    Hannan FM, Athanasou NA, Teh J, Gibbons CL, Shine B, Thakker RV.
    Eur J Endocrinol; 2008 Feb 23; 158(2):265-71. PubMed ID: 18230836
    [Abstract] [Full Text] [Related]

  • 5. Cinacalcet in the management of tumor-induced osteomalacia.
    Geller JL, Khosravi A, Kelly MH, Riminucci M, Adams JS, Collins MT.
    J Bone Miner Res; 2007 Jun 23; 22(6):931-7. PubMed ID: 17352646
    [Abstract] [Full Text] [Related]

  • 6. Reports of 17 Chinese patients with tumor-induced osteomalacia.
    Yu WJ, He JW, Fu WZ, Wang C, Zhang ZL.
    J Bone Miner Metab; 2017 May 23; 35(3):298-307. PubMed ID: 27085966
    [Abstract] [Full Text] [Related]

  • 7. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
    Arai R, Onodera T, Terkawi MA, Mitsuhashi T, Kondo E, Iwasaki N.
    BMC Musculoskelet Disord; 2017 Feb 13; 18(1):79. PubMed ID: 28193220
    [Abstract] [Full Text] [Related]

  • 8. Oncogenic Osteomalacia From a Primary Phosphaturic Mesenchymal Tumor of the Toe: A Case Report.
    Kim I, Rajani R.
    J Foot Ankle Surg; 2016 Feb 13; 55(2):294-8. PubMed ID: 25441266
    [Abstract] [Full Text] [Related]

  • 9. Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation.
    Horng JC, Van Eperen E, Tutton S, Singh R, Shaker JL, Wooldridge AN.
    Osteoporos Int; 2021 Sep 13; 32(9):1895-1898. PubMed ID: 33655402
    [Abstract] [Full Text] [Related]

  • 10. Hypophosphatemia related to a neuro-endocrine tumor of the pancreas: A case report.
    Pickering ME, Bouvier D, Puravet A, Soubrier M, Sapin V, Oris C.
    Clin Biochem; 2022 Jun 13; 104():62-65. PubMed ID: 35337828
    [Abstract] [Full Text] [Related]

  • 11. Octreotide Is Ineffective in Treating Tumor-Induced Osteomalacia: Results of a Short-Term Therapy.
    Ovejero D, El-Maouche D, Brillante BA, Khosravi A, Gafni RI, Collins MT.
    J Bone Miner Res; 2017 Aug 13; 32(8):1667-1671. PubMed ID: 28459498
    [Abstract] [Full Text] [Related]

  • 12. Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients.
    Zuo QY, Wang H, Li W, Niu XH, Huang YH, Chen J, You YH, Liu BY, Cui AM, Deng W.
    BMC Musculoskelet Disord; 2017 Sep 21; 18(1):403. PubMed ID: 28934935
    [Abstract] [Full Text] [Related]

  • 13. Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report.
    Tartaglia F, Minisola S, Sgueglia M, Blasi S, Brunelli D, Degli Effetti E, Maturo A, Cola A, Custureri F, Campana FP.
    G Chir; 2006 Sep 21; 27(1-2):9-13. PubMed ID: 16608626
    [Abstract] [Full Text] [Related]

  • 14. Tumour-induced osteomalacia.
    Minisola S, Peacock M, Fukumoto S, Cipriani C, Pepe J, Tella SH, Collins MT.
    Nat Rev Dis Primers; 2017 Jul 13; 3():17044. PubMed ID: 28703220
    [Abstract] [Full Text] [Related]

  • 15. Oncogenic osteomalacia due to phosphaturic mesenchymal tumour in the upper thoracic spine.
    Garg B, Mehta N, Goyal A, Khadgawat R.
    BMJ Case Rep; 2020 Dec 16; 13(12):. PubMed ID: 33328210
    [Abstract] [Full Text] [Related]

  • 16. Tumor-Induced Osteomalacia.
    Florenzano P, Hartley IR, Jimenez M, Roszko K, Gafni RI, Collins MT.
    Calcif Tissue Int; 2021 Jan 16; 108(1):128-142. PubMed ID: 32504138
    [Abstract] [Full Text] [Related]

  • 17. Tumor-Induced Osteomalacia and the Importance of Plasma Fibroblast Growth Factor 23 as an Indicator: Diagnostic Delay Leads to a Suicide Attempt.
    Seemann L, Padala SA, Mohammed A, Belayneh N.
    J Investig Med High Impact Case Rep; 2019 Jan 16; 7():2324709619895162. PubMed ID: 31850815
    [Abstract] [Full Text] [Related]

  • 18. Tumour-induced osteomalacia: a literature review and a case report.
    Dadoniene J, Miglinas M, Miltiniene D, Vajauskas D, Seinin D, Butenas P, Kacergius T.
    World J Surg Oncol; 2016 Jan 08; 14(1):4. PubMed ID: 26744291
    [Abstract] [Full Text] [Related]

  • 19. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.
    Mori Y, Ogasawara T, Motoi T, Shimizu Y, Chikazu D, Tamura K, Fukumoto S, Takato T.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar 08; 109(3):e57-63. PubMed ID: 20219587
    [Abstract] [Full Text] [Related]

  • 20. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
    Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Jüppner H.
    N Engl J Med; 2003 Apr 24; 348(17):1656-63. PubMed ID: 12711740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.